Customers
Q - I’m on a reagent rental plan, what’s this mean for me?
A – Any customer under a reagent rental plan will be able to continue with their plan until end 2008 (RVA only through April). Nanogen will provide reagents and cartridges as required for the reagent rental plan. We recommend all customers look for an alternative platform/solution for their diagnostic test and notify us of their intended last use. Nanogen will decommission the system from your laboratory at the termination of the reagent rental agreement or sooner if you have transitioned to another system.
Q - How long will you keep selling cartridges?
A – Cartridges for the NanoChip systems will be available for sale based on the following schedule:
- NC400 400 site cartridges will be available for purchase and delivery throughout 2008.
- NC400 100 site cartridges will no longer be available (400 site cartridges can be used in place of 100 site cartridges).
- MBW 100 site cartridges will be available for purchase and delivery throughout 2008.
Q - How long will my instrument be serviced?
A – Warranty and Service Contracts for MBW and NC400 systems will be honored to the end of the contract period. There will be no renewal of service agreements or extensions of contracts. Following the warranty or service agreement period customers may continue to use the MBW or NC400 systems under the recognized terms that Nanogen is not obligated to provide service for the instrument. Parts will be available to service the systems for 2008 and will be billed at standard parts costs. Labor will be made available on an “as needed” basis and will be billed at current standard service rates.
Q - Do you have any other technology that can solve my problems?
A – In addition to our NanoChip electronic microarray technology, Nanogen has a large menu of molecular diagnostic real-time PCR CE-IVD test kits and Analyte Specific Reagents for infectious disease targets. Please visit the Products\Reagents tab on our website for further information.
Investors
Q - What will be the impact on your financials?
A - On an annual basis, we expect to improve our cash flow by at least $15 million per year. We expect revenues on a total basis to continue growing. The combination of growing revenues and reduced expenses will allow the company to reach profitability sooner without the ongoing investment into the array business.
Q - What will the restructuring charges be?
A - Please see our third quarter 10Q filing for specific information regarding financial impact.
|
